DOCS
Undervalued by 130.3% based on the discounted cash flow analysis.
Market cap | $2.91 Billion |
---|---|
Enterprise Value | $2.20 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.66 |
Beta | 0.0 |
Outstanding Shares | 122,161,566 |
Avg 30 Day Volume | 1,684,895 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 21.14 |
---|---|
PEG | 48.84 |
Price to Sales | 8.1 |
Price to Book Ratio | 3.47 |
Enterprise Value to Revenue | 4.7 |
Enterprise Value to EBIT | 13.51 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...